Immunaeon is building infrastructure for the immunotherapy revolution, but with just $0.4M in revenue and 3 employees, they're either massively undervalued or hilariously optimistic. The real question isn't what they do—it's whether they can survive long enough for the market to catch up.

"They're not selling software—they're selling the future of immune system preservation. That's either brilliant positioning or a bridge too far."

Their tech stack reveals a modern, credible approach: Contentful for content, HubSpot for CRM, Cloudflare for infrastructure. This isn't a WordPress hack job—it's a serious technical foundation. But here's the concern: they're in the 'Fitness' industry category, which makes zero sense for immunotherapy. That either means they're pivoting, or their positioning is fundamentally confused.

• Ultra-niche targeting: Immunotherapy preservation is a blue ocean with massive barriers to entry
• Capital efficiency: $0.4M on 3 people suggests they're either pre-seed or running on fumes
• Social presence: Active across 4 platforms but minimal engagement—awareness without traction
• The 'Fitness' miscategorization is either a strategic pivot or a fundamental brand identity crisis